Cargando…
Antiproliferative Activity of a New Quinazolin-4(3H)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common lung cancer subtype. Although chemotherapy and targeted therapy are used for the treatment of patients with NSCLC, the survival rate remains very low. Recent findings suggested that aurora kinase A (AKA), a cell cycle regulator, is a potential ta...
Autores principales: | Lee, Ji Yun, Yang, Huarong, Kim, Donghwa, Kyaw, Kay Zin, Hu, Ruoci, Fan, Yanhua, Lee, Sang Kook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228987/ https://www.ncbi.nlm.nih.gov/pubmed/35745617 http://dx.doi.org/10.3390/ph15060698 |
Ejemplares similares
-
Aurora kinases shed light on resistance to EGFR inhibition in head and neck cancer
por: Kim, Donghwa, et al.
Publicado: (2021) -
Crystal structures of 6-nitroquinazolin-4(3H)-one, 6-aminoquinazolin-4(3H)-one and 4-aminoquinazoline hemihydrochloride dihydrate
por: Turgunov, Kambarali, et al.
Publicado: (2021) -
7-Nitroquinazolin-4(3H)-one
por: Yong, Jian-Ping, et al.
Publicado: (2008) -
2-Chloroquinazolin-4(3H)-one
por: Cao, Dong-Lei, et al.
Publicado: (2012) -
Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity
por: Mirgany, Tebyan O., et al.
Publicado: (2021)